• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过文库规模的变体特征分析对亲和体和纤连蛋白结合位进行序列可开发性作图。

Sequence-developability mapping of affibody and fibronectin paratopes via library-scale variant characterization.

机构信息

Department of Chemical Engineering and Materials Science, University of Minnesota, Twin Cities, Minneapolis, MN 55455, United States.

出版信息

Protein Eng Des Sel. 2024 Jan 29;37. doi: 10.1093/protein/gzae010.

DOI:10.1093/protein/gzae010
PMID:38836499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11170491/
Abstract

Protein developability is requisite for use in therapeutic, diagnostic, or industrial applications. Many developability assays are low throughput, which limits their utility to the later stages of protein discovery and evolution. Recent approaches enable experimental or computational assessment of many more variants, yet the breadth of applicability across protein families and developability metrics is uncertain. Here, three library-scale assays-on-yeast protease, split green fluorescent protein (GFP), and non-specific binding-were evaluated for their ability to predict two key developability outcomes (thermal stability and recombinant expression) for the small protein scaffolds affibody and fibronectin. The assays' predictive capabilities were assessed via both linear correlation and machine learning models trained on the library-scale assay data. The on-yeast protease assay is highly predictive of thermal stability for both scaffolds, and the split-GFP assay is informative of affibody thermal stability and expression. The library-scale data was used to map sequence-developability landscapes for affibody and fibronectin binding paratopes, which guides future design of variants and libraries.

摘要

蛋白质的可开发性是其在治疗、诊断或工业应用中的必要条件。许多可开发性测定方法的通量较低,这限制了它们在蛋白质发现和进化的后期阶段的应用。最近的方法可以对更多的变体进行实验或计算评估,但蛋白质家族和可开发性指标的适用范围尚不确定。在这里,三种基于酵母蛋白酶、分裂绿色荧光蛋白(GFP)和非特异性结合的文库规模测定方法,用于预测小分子蛋白支架亲和体和纤维连接蛋白的两个关键可开发性结果(热稳定性和重组表达)。通过基于文库规模测定数据的线性相关和机器学习模型,评估了这些测定方法的预测能力。酵母蛋白酶测定法对两种支架的热稳定性都具有高度的预测性,而分裂 GFP 测定法对亲和体的热稳定性和表达情况具有信息性。文库规模的数据用于绘制亲和体和纤维连接蛋白结合表位的序列可开发性图谱,指导未来变体和文库的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d5/11170491/706790a8d0b7/gzae010ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d5/11170491/706790a8d0b7/gzae010ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d5/11170491/706790a8d0b7/gzae010ga1.jpg

相似文献

1
Sequence-developability mapping of affibody and fibronectin paratopes via library-scale variant characterization.通过文库规模的变体特征分析对亲和体和纤连蛋白结合位进行序列可开发性作图。
Protein Eng Des Sel. 2024 Jan 29;37. doi: 10.1093/protein/gzae010.
2
Engineering Affibody Binders to Death Receptor 5 and Tumor Necrosis Factor Receptor 1 With Improved Stability.工程化亲和力体结合物至死亡受体5和肿瘤坏死因子受体1并提高稳定性
Biotechnol Bioeng. 2025 Jun;122(6):1386-1396. doi: 10.1002/bit.28954. Epub 2025 Mar 5.
3
High-throughput developability assays enable library-scale identification of producible protein scaffold variants.高通量可开发性分析能够在文库规模上鉴定可生产的蛋白质支架变体。
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23). doi: 10.1073/pnas.2026658118.
4
Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276.基于细胞的筛选有助于酵母展示发现真正的细胞结合配体:针对肿瘤血管生物标志物 CD276。
ACS Comb Sci. 2019 Mar 11;21(3):207-222. doi: 10.1021/acscombsci.8b00156. Epub 2019 Jan 24.
5
Determinants of Developability and Evolvability of Synthetic Miniproteins as Ligand Scaffolds.合成小蛋白作为配体支架的可开发性和可进化性的决定因素。
J Mol Biol. 2023 Dec 15;435(24):168339. doi: 10.1016/j.jmb.2023.168339. Epub 2023 Nov 3.
6
Thermal green protein, an extremely stable, nonaggregating fluorescent protein created by structure-guided surface engineering.热绿色蛋白,一种通过结构导向表面工程构建的极其稳定、不聚集的荧光蛋白。
Proteins. 2015 Jul;83(7):1225-37. doi: 10.1002/prot.24699. Epub 2015 May 8.
7
Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.基于人纤连蛋白III型结构域的多样化蛋白质文库的设计、表达及稳定性
Protein Sci. 2007 Mar;16(3):476-84. doi: 10.1110/ps.062498407.
8
Monitored whole gene in vitro evolution of an anti-hRaf-1 affibody molecule towards increased binding affinity.监测抗 hRaf-1 亲和体分子的整个基因体外进化以提高结合亲和力。
N Biotechnol. 2012 Jun 15;29(5):534-42. doi: 10.1016/j.nbt.2011.10.008. Epub 2011 Oct 19.
9
Hyperstable Synthetic Mini-Proteins as Effective Ligand Scaffolds.超稳定合成微型蛋白作为有效的配体支架
ACS Synth Biol. 2023 Dec 15;12(12):3608-3622. doi: 10.1021/acssynbio.3c00409. Epub 2023 Nov 27.
10
Rosetta comparative modeling for library design: Engineering alternative inducer specificity in a transcription factor.用于文库设计的Rosetta比较建模:工程化转录因子中的替代诱导物特异性
Proteins. 2015 Jul;83(7):1327-40. doi: 10.1002/prot.24828. Epub 2015 May 29.

引用本文的文献

1
Applying Computational Protein Design to Engineer Affibodies for Affinity-controlled Delivery of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor.应用计算蛋白质设计工程化亲合体以实现血管内皮生长因子和血小板衍生生长因子的亲和控制递送。
Biomacromolecules. 2025 Jun 9;26(6):3463-3480. doi: 10.1021/acs.biomac.5c00097. Epub 2025 May 9.
2
Engineering Affibody Binders to Death Receptor 5 and Tumor Necrosis Factor Receptor 1 With Improved Stability.工程化亲和力体结合物至死亡受体5和肿瘤坏死因子受体1并提高稳定性
Biotechnol Bioeng. 2025 Jun;122(6):1386-1396. doi: 10.1002/bit.28954. Epub 2025 Mar 5.

本文引用的文献

1
Generalized biomolecular modeling and design with RoseTTAFold All-Atom.基于 RoseTTAFold All-Atom 的广义生物分子建模与设计。
Science. 2024 Apr 19;384(6693):eadl2528. doi: 10.1126/science.adl2528.
2
Hyperstable Synthetic Mini-Proteins as Effective Ligand Scaffolds.超稳定合成微型蛋白作为有效的配体支架
ACS Synth Biol. 2023 Dec 15;12(12):3608-3622. doi: 10.1021/acssynbio.3c00409. Epub 2023 Nov 27.
3
Determinants of Developability and Evolvability of Synthetic Miniproteins as Ligand Scaffolds.合成小蛋白作为配体支架的可开发性和可进化性的决定因素。
J Mol Biol. 2023 Dec 15;435(24):168339. doi: 10.1016/j.jmb.2023.168339. Epub 2023 Nov 3.
4
Predicting and Interpreting Protein Developability Via Transfer of Convolutional Sequence Representation.通过卷积序列表示的转移来预测和解释蛋白质可开发性。
ACS Synth Biol. 2023 Sep 15;12(9):2600-2615. doi: 10.1021/acssynbio.3c00196. Epub 2023 Aug 29.
5
Mega-scale experimental analysis of protein folding stability in biology and design.大规模实验分析生物学和设计中的蛋白质折叠稳定性。
Nature. 2023 Aug;620(7973):434-444. doi: 10.1038/s41586-023-06328-6. Epub 2023 Jul 19.
6
De novo design of protein structure and function with RFdiffusion.利用 RFdiffusion 从头设计蛋白质结构和功能。
Nature. 2023 Aug;620(7976):1089-1100. doi: 10.1038/s41586-023-06415-8. Epub 2023 Jul 11.
7
Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches.利用高通量体外和计算方法鉴定抗体临床进展的可开发性风险。
MAbs. 2023 Jan-Dec;15(1):2200540. doi: 10.1080/19420862.2023.2200540.
8
Assessing developability early in the discovery process for novel biologics.评估新型生物制剂发现过程中的可开发性。
MAbs. 2023 Jan-Dec;15(1):2171248. doi: 10.1080/19420862.2023.2171248.
9
Antibodies to watch in 2022.2022 年值得关注的抗体药物
MAbs. 2022 Jan-Dec;14(1):2014296. doi: 10.1080/19420862.2021.2014296.
10
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.